Rhopr-SK-2 is a tyrosine-sulfated, C-terminally amidated neuropeptide with the sequence GGDDQY(SO₃H)GFGLFF-NH₂ (non-sulfated variant: GGDDQYGFGLFF-NH₂) . Key structural features include:
Sulfation: Critical for receptor binding and bioactivity, as shown by reduced potency in non-sulfated analogs .
| Property | Value/Description | Source |
|---|---|---|
| Molecular Weight | ~1,200 Da (sulfated form) | |
| Synthesis Method | Solid-phase peptide synthesis (SPPS) | |
| Post-Translational Modifications | Tyrosine sulfation, C-terminal amidation |
Rhopr-SK-2 functions as a feeding satiety factor and myomodulator:
Feeding Regulation:
Muscle Contraction:
Rhopr-SK-2 binds to G protein-coupled receptors (GPCRs) homologous to vertebrate cholecystokinin receptors (CCKR):
Receptor Affinity: EC₅₀ values in the low nanomolar range (0.1–1 nM) for sulfated forms, compared to micromolar potency for non-sulfated analogs .
Downstream Effects:
| Feature | Rhopr-SK-1 | Rhopr-SK-2 |
|---|---|---|
| Sequence | pQSKVDDY(SO₃H)GHGLFW-NH₂ | GGDDQY(SO₃H)GFGLFF-NH₂ |
| Receptor Specificity | Binds SKR1 and SKR2 | Primarily binds SKR2 |
| Feeding Inhibition | Moderate (20–30% reduction) | Strong (30–40% reduction) |
| Tissue Distribution | CNS, midgut, hindgut | CNS, posterior midgut, body wall |
Pest Control: RNA interference (RNAi) targeting Rhopr-SK-2 increases feeding rates in R. prolixus, suggesting potential for vector population management .
Neurological Studies: Fluorescent in situ hybridization (FISH) localizes Rhopr-SK-2 transcripts to median neurosecretory cells (MNCs) in the brain, highlighting its role in neuroendocrine signaling .
Sulfakinins (SKs) are a family of multifunctional neuropeptides that have demonstrated myotropic activity on muscles of the digestive system and function as feeding satiety factors. In Rhodnius prolixus, two sulfakinins have been identified and confirmed through cloning: Rhopr-SK-1 and Rhopr-SK-2 . These neuropeptides are part of a larger family of signaling molecules that play critical roles in various physiological processes, particularly in feeding regulation and gut motility .
Rhopr-SK-2 possesses a unique structural characteristic that distinguishes it from other sulfakinins. At the carboxyl-terminus, Rhopr-SK-2 contains a tyrosyl residue in place of the histidine amino acid that is present in all other SK sequences . This structural variation may contribute to distinct functional properties specific to Rhopr-SK-2. Like other sulfakinins, Rhopr-SK-2 contains a tyrosine residue that can be post-translationally modified by the addition of a sulfate group, which appears to be critical for its biological activity .
Two primary post-translational modifications are critical for Rhopr-SK-2 functionality:
Tyrosine sulfation: Research indicates that sulfation of the tyrosine residue is crucial for receptor activation and biological function. Both sulfated and non-sulfated forms of SK peptides have been detected in neural extracts, but the sulfated forms demonstrate significantly higher potency in receptor activation .
C-terminal amidation: Glycine residues in the precursor peptide are required for amidation of the C-terminus, which is necessary for bioactivity. These glycine residues are indicated in the cDNA sequence of the Rhopr-SK precursor .
These modifications are processed through enzymatic pathways involving cleavage at mono- and dibasic lysine and arginine sites, followed by specific enzyme-mediated addition of functional groups .
Reverse transcriptase quantitative PCR (RT-qPCR) analysis demonstrates that the Rhopr-SK transcript is predominantly expressed in the central nervous system (CNS) of unfed fifth-instar R. prolixus . Within the CNS, transcript expression levels are highest in the brain and subesophageal ganglion (SOG), with little or no expression in the mesothoracic ganglionic mass (MTGM) and prothoracic ganglion (PRO) . Importantly, fluorescent in situ hybridization shows transcript expression exclusively in neurons in the brain .
When examining protein distribution using immunohistochemical staining, SK-like peptides were observed in the same neurons in the brain and in processes extending throughout the CNS, as well as over the posterior midgut and anterior hindgut . This distribution pattern suggests that Rhopr-SK-2 may act both centrally (in the CNS) and peripherally (in the digestive system) to regulate physiological processes.
For comprehensive tissue-specific expression analysis of Rhopr-SK-2, researchers should consider a multi-technique approach:
RT-qPCR: For quantitative measurement of transcript expression across different tissues (CNS, midgut, hindgut) and within CNS regions (brain, SOG, MTGM, PRO) .
Fluorescent in situ hybridization (FISH): To visualize the specific neurons expressing the Rhopr-SK transcript in the brain and other neural tissues .
Immunohistochemistry: Using antibodies against SK-like peptides to detect the distribution of the processed neuropeptides throughout the nervous system and gut tissues .
This combined approach provides complementary data on both transcript and protein distribution, offering insights into sites of synthesis versus sites of action.
The satiety-inducing effect of sulfakinins is evolutionarily conserved across diverse animal groups. For example, similar roles have been observed in other insects and even in distantly related organisms. This suggests an ancient role of SK/CCK-type neuropeptides as inhibitory regulators of feeding-related processes in the Bilateria has been conserved through evolution .
Rhopr-SK-2, like other sulfakinins, demonstrates myotropic activity on the digestive system muscles. Specifically, Rhopr-SK-1 in its sulfated form has been shown to induce contractions of the hindgut in a dose-dependent manner . The presence of SK-like peptides over the posterior midgut and anterior hindgut, as revealed by immunohistochemical staining, further supports a direct role in regulating gut motility .
Tyrosine sulfation appears to be crucial for the biological activity of Rhopr-SK-2. Drawing parallels from studies on SK/CCK-type systems in other organisms, the sulfated forms of SK/CCK peptides demonstrate significantly higher potency in receptor activation compared to non-sulfated forms.
For instance, in starfish Asterias rubens, experiments with sulfated and non-sulfated forms of SK/CCK peptides showed that:
| Peptide Form | EC₅₀ Value for Receptor Activation |
|---|---|
| ArSK/CCK1 (sulfated) | 0.25 nM |
| ArSK/CCK2 (sulfated) | 0.12 nM |
| ArSK/CCK2 (non-sulfated) | 48 μM |
This represents a difference of five to six orders of magnitude in potency between sulfated and non-sulfated forms . Similar mechanisms likely apply to Rhopr-SK-2, where sulfation of the tyrosine residue would greatly enhance its ability to activate its cognate receptor and elicit physiological responses.
For recombinant production of Rhopr-SK-2, researchers should consider the following methodological approach:
Cloning and expression vector construction: Based on the confirmed cDNA sequence, design primers to amplify the Rhopr-SK coding region. Insert this into an appropriate expression vector containing necessary regulatory elements and tags for purification .
Expression system selection: Choose between prokaryotic (E. coli) or eukaryotic (insect cells, yeast) expression systems. Given the importance of post-translational modifications, particularly tyrosine sulfation, a eukaryotic expression system may be preferable to ensure proper processing.
Post-translational modification consideration: If using a system that cannot perform tyrosine sulfation, consider chemical sulfation of the purified recombinant peptide, as the sulfated form has been shown to be significantly more bioactive .
Purification strategy: Implement a multi-step purification process, typically involving affinity chromatography based on fusion tags, followed by size exclusion and/or reverse-phase chromatography to obtain highly pure Rhopr-SK-2.
Validation: Confirm the identity and purity of the recombinant peptide using mass spectrometry, which can also verify the presence of post-translational modifications .
Based on the known physiological effects of sulfakinins, researchers can design several bioassays to measure Rhopr-SK-2 activity:
Hindgut contraction assay: Isolate the hindgut from R. prolixus and mount it in a suitable physiological saline. Connect to a force displacement transducer to monitor contractions. Apply recombinant Rhopr-SK-2 at various concentrations and measure the contractile response . Parameters to measure include:
Contraction amplitude
Frequency of contractions
Threshold concentration for response
EC₅₀ value
Feeding inhibition assay: Inject different concentrations of recombinant Rhopr-SK-2 into unfed R. prolixus and measure:
Receptor activation assay: Using cells transfected with the Rhopr-SK receptor, measure the activation response using:
For all these assays, it is crucial to include both sulfated and non-sulfated versions of Rhopr-SK-2 to compare their relative potencies.
As R. prolixus is a vector of Chagas' disease, understanding the physiological roles of Rhopr-SK-2 could contribute to novel vector control strategies. Research approaches may include:
Targeted disruption of feeding behavior: Since Rhopr-SK-2 functions as a satiety factor, developing compounds that mimic or enhance its activity could potentially disrupt normal feeding patterns of the insect, reducing blood meal consumption and subsequently affecting vector capacity .
Gut motility modulation: The myotropic effects of Rhopr-SK-2 on hindgut contractions suggest that targeting this pathway could interfere with digestion and waste elimination, potentially affecting survival and reproduction .
Receptor-targeted approaches: Identifying compounds that act as agonists of the Rhopr-SK receptor could provide tools for disrupting normal physiological processes regulated by the SK signaling system.
Genetic manipulation strategies: CRISPR/Cas9 or RNAi-based approaches targeting Rhopr-SK-2 or its receptor could help evaluate the potential of this signaling pathway as a target for vector control.
Investigating receptor-ligand interactions for Rhopr-SK-2 presents several methodological challenges:
Receptor identification and characterization: While SK receptors have been identified in other species, specific characterization of the Rhopr-SK-2 receptor is necessary to understand binding specificity and downstream signaling pathways.
Post-translational modification effects: The dramatic difference in potency between sulfated and non-sulfated forms (as observed in other SK/CCK systems) necessitates careful consideration of post-translational modifications in experimental design .
In vitro versus in vivo activity: Receptor activation in heterologous expression systems may not fully recapitulate the complexity of in vivo signaling networks, requiring complementary approaches to validate findings.
Structural determinants of binding: The unusual substitution of a tyrosyl residue for histidine at the carboxyl-terminus of Rhopr-SK-2 may influence receptor binding properties compared to other SKs , requiring detailed structure-function studies.
To address these challenges, researchers should consider employing a combination of techniques including:
Heterologous expression of receptors
Competitive binding assays
Molecular modeling and docking simulations
Mutagenesis studies targeting key residues
BRET/FRET approaches to monitor receptor-ligand interactions in real-time
Several aspects of Rhopr-SK-2 signaling remain incompletely understood and merit further investigation:
Receptor subtypes and specificity: Determining whether Rhopr-SK-2 acts through the same receptor as Rhopr-SK-1 or if multiple receptor subtypes exist with differential affinities.
Interplay with other neuropeptide systems: Investigating potential cross-talk between Rhopr-SK-2 and other neuropeptide systems involved in feeding regulation and gut motility.
Developmental regulation: Examining how Rhopr-SK-2 expression and function change across different developmental stages of R. prolixus.
Neural circuits: Mapping the complete neural circuits through which Rhopr-SK-2 exerts its effects on feeding behavior and gut motility.
Evolutionary conservation: Comparative studies to understand how the unique structural features of Rhopr-SK-2 (particularly the tyrosyl substitution) influence its function compared to SKs in other species.
When researchers encounter contradictory findings regarding Rhopr-SK-2 function or mechanisms, several experimental approaches can help reconcile these discrepancies:
Standardization of peptide preparations: Ensure consistent post-translational modifications, particularly sulfation status, as this dramatically affects potency .
Physiological state considerations: Account for differences in feeding state, developmental stage, and sex of the experimental animals, as these factors may influence responsiveness to Rhopr-SK-2.
Dose-response relationships: Establish complete dose-response curves rather than testing single concentrations, as effects may be biphasic or threshold-dependent.
Temporal dynamics: Investigate both acute and chronic effects of Rhopr-SK-2, as adaptive responses may occur with prolonged exposure.
Context-dependent effects: Test Rhopr-SK-2 activity under different physiological contexts (fed vs. unfed, stressed vs. unstressed) to understand conditional effects.
Methodological triangulation: Employ multiple complementary techniques (electrophysiology, calcium imaging, behavioral assays) to build a comprehensive understanding of Rhopr-SK-2 function.